These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23859267)

  • 1. Drug target prioritization in Plasmodium falciparum through metabolic network analysis, and inhibitor designing using virtual screening and docking approach.
    Yadav MK; Pandey SK; Swati D
    J Bioinform Comput Biol; 2013 Aug; 11(4):1350003. PubMed ID: 23859267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in silico screening and X-ray structure analysis of the inhibitor complex of Plasmodium falciparum orotidine 5'-monophosphate decarboxylase.
    Takashima Y; Mizohata E; Krungkrai SR; Fukunishi Y; Kinoshita T; Sakata T; Matsumura H; Krungkrai J; Horii T; Inoue T
    J Biochem; 2012 Aug; 152(2):133-8. PubMed ID: 22740703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of inhibitors of ODCase.
    Mundra S; Kotra LP
    Future Med Chem; 2014 Feb; 6(2):165-77. PubMed ID: 24467242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent, covalent inhibitor of orotidine 5'-monophosphate decarboxylase with antimalarial activity.
    Bello AM; Poduch E; Fujihashi M; Amani M; Li Y; Crandall I; Hui R; Lee PI; Kain KC; Pai EF; Kotra LP
    J Med Chem; 2007 Mar; 50(5):915-21. PubMed ID: 17290979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and inhibition of orotidine 5'-monophosphate decarboxylase from Plasmodium falciparum.
    Langley DB; Shojaei M; Chan C; Lok HC; Mackay JP; Traut TW; Guss JM; Christopherson RI
    Biochemistry; 2008 Mar; 47(12):3842-54. PubMed ID: 18303855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cytidine-based orotidine-5'-monophosphate decarboxylase inhibitors with an unusual twist.
    Purohit MK; Poduch E; Wei LW; Crandall IE; To T; Kain KC; Pai EF; Kotra LP
    J Med Chem; 2012 Nov; 55(22):9988-97. PubMed ID: 22991951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-refinement of Plasmodium falciparum orotidine 5'-monophosphate decarboxylase provides a clearer picture of an important malarial drug target.
    Novak WRP; West KHJ; Kirkman LMD; Brandt GS
    Acta Crystallogr F Struct Biol Commun; 2018 Oct; 74(Pt 10):664-668. PubMed ID: 30279319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel enzyme complex of orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase in human malaria parasite Plasmodium falciparum: physical association, kinetics, and inhibition characterization.
    Krungkrai SR; DelFraino BJ; Smiley JA; Prapunwattana P; Mitamura T; Horii T; Krungkrai J
    Biochemistry; 2005 Feb; 44(5):1643-52. PubMed ID: 15683248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the decarboxylation of orotidine 5'-monophosphate (OMP) by Plasmodium falciparum OMP decarboxylase.
    Tokuoka K; Kusakari Y; Krungkrai SR; Matsumura H; Kai Y; Krungkrai J; Horii T; Inoue T
    J Biochem; 2008 Jan; 143(1):69-78. PubMed ID: 17981823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orotidine Monophosphate Decarboxylase--A Fascinating Workhorse Enzyme with Therapeutic Potential.
    Fujihashi M; Mnpotra JS; Mishra RK; Pai EF; Kotra LP
    J Genet Genomics; 2015 May; 42(5):221-34. PubMed ID: 26059770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D QSAR, pharmacophore and molecular docking studies of known inhibitors and designing of novel inhibitors for M18 aspartyl aminopeptidase of Plasmodium falciparum.
    Kumari M; Chandra S; Tiwari N; Subbarao N
    BMC Struct Biol; 2016 Aug; 16():12. PubMed ID: 27534744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique insertion of low complexity amino acid sequence underlies protein-protein interaction in human malaria parasite orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase.
    Imprasittichail W; Roytrakul S; Krungkrai SR; Krungkrail J
    Asian Pac J Trop Med; 2014 Mar; 7(3):184-92. PubMed ID: 24507637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of C6-uridine derivatives targeting plasmodia orotidine monophosphate decarboxylase.
    Bello AM; Poduch E; Liu Y; Wei L; Crandall I; Wang X; Dyanand C; Kain KC; Pai EF; Kotra LP
    J Med Chem; 2008 Feb; 51(3):439-48. PubMed ID: 18189347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics.
    Poduch E; Bello AM; Tang S; Fujihashi M; Pai EF; Kotra LP
    J Med Chem; 2006 Aug; 49(16):4937-45. PubMed ID: 16884305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of inhibitor complexes reveal an alternate binding mode in orotidine-5'-monophosphate decarboxylase.
    Wu N; Pai EF
    J Biol Chem; 2002 Aug; 277(31):28080-7. PubMed ID: 12011084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.
    Thillainayagam M; Malathi K; Ramaiah S
    J Biomol Struct Dyn; 2018 Nov; 36(15):3993-4009. PubMed ID: 29132266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening.
    Batool S; Khan ZA; Kamal W; Mushtaq G; Kamal MA
    Med Chem; 2015; 11(7):687-700. PubMed ID: 25741881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate binding induces domain movements in orotidine 5'-monophosphate decarboxylase.
    Harris P; Poulsen JC; Jensen KF; Larsen S
    J Mol Biol; 2002 May; 318(4):1019-29. PubMed ID: 12054799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity.
    Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S
    SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.